Supplementary Figure S6 from Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation | Synapse
September 4, 2024
Supplementary Figure S6 from Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Supplementary Figure S6 shows single-cell RNA sequencing data from 5 HGSC tumors, with cell-specific markers and EHMT1 and EHMT2.